Qrons Inc.’s Jonah Meer Joins Everett Jolly on the Stock Day Podcast (QRON) November 5, 2019. – Stock Day Media

Posted: Published on November 11th, 2019

This post was added by Alex Diaz-Granados

About Qrons Inc.

Headquartered in New York City, Qrons is a publicly traded emerging biotechnology company developing advanced stem cell-based solutions to combat neuronal injuries with a laser focus on traumatic brain injuries and concussions. The Company has two product candidates for treating TBIs, both integrating proprietary, modified mesenchymal stem cells (MSCs) and smart synthetic material, QS100, an injury specific, 3D printable, implantable MSCs-synthetic hydro gel, to treat penetrating brain injuries and QS200, an inject able Ms Cs-synthetic hydro gel for the treatment of diffused injuries commonly referred to as concussions.

The Company is a party to a license and research funding agreement and related service agreements with Ariel Scientific Innovations Ltd., a wholly owned subsidiary of Ariel University, based in Ariel, Israel, and in addition to the world-wide exclusive intellectual property license, a Sponsored Research Agreement with Dartmouth College funding further research with Professor Chenfeng Ke and his team in the Chemistry Department, to develop innovative 3D printable, bio-compatible advanced materials. For additional information, please visit http://www.qrons.com.

Read more from the original source:
Qrons Inc.'s Jonah Meer Joins Everett Jolly on the Stock Day Podcast (QRON) November 5, 2019. - Stock Day Media

Related Posts
This entry was posted in Brain Injury Treatment. Bookmark the permalink.

Comments are closed.